Format

Send to

Choose Destination
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.

Author information

1
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. francesco.sardanelli@unimi.it.
2
Department of Radiology, Research Hospital Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy. francesco.sardanelli@unimi.it.
3
Department of Radiology, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.
4
Department of Radiology, Reina Sofía Hospital, Avda. Menéndez Pidal, s/n 14004, Córdoba, Spain.
5
Department of Radiology, Karolinska University Hospital, Karolinska vägen, 171 76, Solna, Stockholm, Sweden.
6
Department of Radiology, Meander Medical Center, Maatweg 3, 3813, Amersfoort, The Netherlands.
7
Department of Radiology, Gustave-Roussy Institute, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
8
Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna/Vienna General Hospital, Währinger Gürtel 18-20, 1090, Wien, Austria.
9
Clinic of Radiology, University Clinical Center Sarajevo, Bolnička 25, 71000, Sarajevo, Bosnia and Herzegovina.
10
Clinic of Radiology, Charité, Universitätsmedizin Berlin, 10117, Berlin, Germany.
11
Diagnostic Imaging Center, Institute of Oncology, Institutski put 4, 21204, Sremska Kamenica, Serbia.
12
Radiology Department, National Cancer Institute, Santariskiu 1, Vilnius University, Vilnius, Lithuania.
13
Department of Diagnostic and Interventional Radiology, University Hospital 'Dubrava', University of Zagreb School of Medicine, Avenija Gojka Šuška 6, 10000, Zagreb, Croatia.
14
Department of Radiology, Hospital de la Ribera, Carretera de Corbera, Km. 1, 46600, Alzira, Valencia, Spain.
15
Radiology Unit, Hospices Civils de Lyon, Centre Hospitalo-Universitaire Lyon Sud, 165 Chemin du Grand Revoyet, 69495, Pierre Bénite Cedex, France.
16
Nottingham Breast Institute, Nottingham University Hospitals, Hucknall Rd, Nottingham, NG5 1PB, United Kingdom.
17
Department of Radiology, Charles University in Prague, First Faculty of Medicine, U Nemocnice 2, 128 08, Praha 2, Czech Republic.
18
Department of Radiology, ImageRive, Rue de Rive 1, 1204, Genève, Switzerland.
19
Department of Radiology, Acibadem University Maslak Hospital, Buyukdere cd, Maslak, Sariyer, 34457, İstanbul, Turkey.
20
Dundee Cancer Centre, Clinical Research Centre, Ninewells Hospital, and Medical School, Tom McDonald Avenue, Dundee, UK.
21
Division of General Radiology, Department of Radiology, Medical University Graz, Auenbruggerplatz 9, 8036, Graz, Austria.
22
Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Hills Road CB2 0QQ, Cambridge, UK.
23
Institute of Radiology, ACC Steyr, Stadtplatz 30, 4400, Steyr, Austria.
24
Department of Radiology, Mater Misericordiae University Hospital/BreastCheck, BreastCheck, 36 Eccles St, Dublin 7, Ireland.
25
Referenzzentrum Mammographie Munchen, Sonnenstraße 29, 80331, Munich, Germany.
26
Diagnostic Department of Radiology, Tokuda Hospital Sofia, 1407, Sofia, 51B N Vaptsarov Blvd., Bulgaria.
27
Department of Radiology, Landspitali University Hospital, 108, Reykjavik, Iceland.
28
University Hospital of Aachen, Rheinisch-Westfälische Technische Hochschule, Pauwelsstraße 30, 52074, Aachen, Germany.
29
Radiotherapy I, The Oncology Institute 'Prof. Dr. Ion Chiricuta', Cluj-Napoca, 34-36 Republicii Street, RO-400015, Romania.
30
Department of Radiology Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Cracow Branch, Cracow, Poland.
31
Department of Radiology, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
32
Department of Radiology/Breast Imaging, Instituto Português de Oncologia de Lisboa, Rua Professor Lima Basto, 1099-023, Lisboa, Portugal.
33
U.O. Radiodiagnostica, Candiolo Cancer Institute - FPO, IRCCS, Str. Prov. 142, km 3.95, 10060, Candiolo, Turin, Italy.
34
Genitourinary Radiology, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium.
35
Klinik für Radiologie, Neuroradiologie & Nuklearmedizin, Klinikum Frankfurt Hoechst, Frankfurt, Germany.
36
Diagnoscan, SZTE Radiológiai Klinika, Szeged, Semmelweis u. 6, 6725, Szeged, Hungary.
37
Breast Imaging Unit, Scientific Institute (IRCCS) Ospedale San Raffaele, Via Olgettina, 60, 20132, Milan, Italy.
38
Department of Radiological, Oncological and Pathological Sciences, Sapienza University, Viale Regina Elena, 324, 00161, Rome, Italy.
39
Department of Imaging, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
40
Department of Diagnostic Radiology, Oulu University Hospital, Kajaanintie 50, 90220, Oulu, Finland.
41
Department of Radiology and Medical Imaging, State University of Medicine and Pharmacy 'Nicolae Testemitanu', bul. St.cel Mare 165, Chisinau, MD 2012, Moldova.
42
Italian Group for Mammographic Screening (GISMa); Senology Unit, Local Health Authority, Bologna, Italy.
43
Marlene Greenebaum Diagnostic Breast Center, Department of Radiology, Hadassah Hebrew University Hospital, Hadassah Ein Kerem Medical Center, 91120, Jerusalem, Israel.
44
Clinic of Radiology, Alexander Dubček University of Trenčín in Trenčín, Faculty of Healthcare, Študentská 2, 911 50, Trenčín, Slovakia.
45
Radiology Centre, North Estonia Medical Centre, 19 Sütiste Street, 13419, Tallinn, Estonia.
46
Department of Radiology, Hôpital Lapeyronie, 371 Av. du Doyen Gaston Giraud, 34295, Montpellier, France.
47
Department of Radiology, Research Hospital Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy.
48
Department of Radiology, Rigshospitalet Blegdamsvej and Glostrup, Mammography Screening Programme in Capital Region, Blegdamsvej 9, 2100, Copenhagen, Denmark.
49
Diagnostic Mammography Center, Kifisias 362, Chalandri, 15233, Athens, Greece.
50
Duna Medical Center, Lechner Ödön fasor 7, 1095, Budapest, Hungary.

Abstract

EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged.

KEY POINTS:

• EUSOBI and 30 national breast radiology bodies support screening mammography. • A first priority is double-reading biennial mammography for women aged 50-69 years. • Extension to 73-75 and from 40-45 to 49 years is also encouraged. • Digital mammography (not film-screen or computer radiography) should be used. • DBT is set to become "routine mammography" in the screening setting in the next future.

KEYWORDS:

Breast cancer; Digital breast tomosynthesis (DBT); Digital mammography; Population-based screening; Recall rate

PMID:
27807699
PMCID:
PMC5486792
DOI:
10.1007/s00330-016-4612-z
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center